5 Broker-Liked Stocks to Watch Amid Fed's First Rate Hike in 3 Years

The Federal Reserve raised its target rate 25bps to 3.75%-4.00%, its first hike in three years, and indicated another increase could follow this year as inflation is not expected to return to the 2% target until after 2028. Against this more restrictive backdrop, Zacks highlighted Beazer Homes, Best Buy, Alaska Air, RXO and AMN Healthcare based on recent broker upgrades, earnings-estimate revisions and valuation/liquidity screens. Beazer posted an average earnings beat of 29.9% over the past four quarters and its current-quarter revenue estimate is up 5.2% year over year, while AMN's average beat was 96.6%; RXO remains the most qualified selection due to a 22.9% average earnings miss and execution risk.

Analysis

The screen is mechanically biased toward low price-to-sales companies with recent estimate momentum, a combination that can work in a soft-landing regime but is not independently predictive once rates are repriced. BZH has the clearest macro sensitivity: higher mortgage rates raise cancellation and incentive risk disproportionately for smaller builders with less land-bank flexibility than DHI, LEN, or PHM. Its energy-efficiency positioning may support relative absorption, but the relevant 1-3 month datapoints are weekly mortgage applications, resale inventory, and gross-margin guidance—not broker revisions.

BBY is the higher-quality expression if consumer demand remains resilient because services, advertising, marketplace, and membership mix can protect EBIT dollars better than pure discretionary retailers. The contrarian issue is that AI-device replacement expectations are increasingly consensus; a weak back-to-school or holiday preannouncement would expose limited hardware pricing power and likely compress the multiple. Prefer BBY over WMT or TGT only if comparable-sales guidance is sustained without incremental promotional investment.

ALK's Hawaiian integration creates a 6-18 month network and loyalty optionality, but the near-term equity is more exposed to fuel and capacity discipline than to loyalty rhetoric. A crude spike or industry-wide domestic fare discounting would overwhelm synergy estimates. RXO and AMN are operational turnarounds rather than clean rate-cut beneficiaries: each needs sequential gross-margin evidence before estimate revisions should be trusted, with AMN particularly vulnerable if hospitals revert from flexible staffing to permanent hiring.

Overall, this is insufficiently differentiated news to chase at the open. The useful signal is dispersion: own durable margin mix at BBY, monitor BZH as a high-beta housing-rate proxy, and demand execution proof from RXO/AMN before underwriting a cyclical recovery.

Key Decisions for Investors

• Initiate a 3-month pair: long BBY / short TGT in equal dollar amounts, only after BBY confirms stable comp-sales and gross margin. Target 10-15% relative return; exit if BBY guides to heavier promotions or TGT shows a two-quarter discretionary-sales inflection.
• Use BZH only as a tactical housing-beta long on a sustained decline in the 10-year Treasury yield and improving mortgage-purchase applications; size below 100 bps of NAV. Target 15-20% upside over 1-3 months, with a stop on rising cancellation commentary or gross-margin guidance below plan; alternatively hedge with short ITB.
• Do not initiate RXO or AMN on estimate revisions alone. Set an earnings alert for sequential improvement in RXO brokerage gross margin and AMN nurse-staffing revenue/margin; absent those metrics, the downside from another reset exceeds identifiable near-term upside.
• For ALK, wait for post-integration capacity and unit-revenue guidance before adding exposure. A long ALK / short JETS trade is attractive only if crude remains contained and ALK demonstrates positive unit-revenue growth versus industry; invalidate on a material fuel-cost guidance increase or fare-war commentary.